M K Proteins (MKPL)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/Equity is only 0.03 and Piotroski F-Score is 7/9, indicating a conservatively financed and financially stable balance sheet.
• Reported sales growth of 126.85% shows strong top-line momentum, with latest quarter sales at ₹90 Cr.
• Promoter holding of 74.82% aligns promoter interests with minority shareholders.
• ROE of 13.00% and ROCE of 12.87% are reasonable, especially for a small-cap edible-oil company.

Concerns

• Latest quarter net profit of ₹1 Cr on ₹90 Cr sales implies a razor-thin margin of roughly 1%, showing weak pricing power.
• Profit growth of only 3.62% lags far behind sales growth of 126.85%, so the company is not converting revenue growth into shareholder earnings.
• Valuation is rich: P/E of 22.46, P/B of 3.03, and no dividend; the price/earnings multiple is high for a low-margin commodity business.
• Edible oil is a commodity industry with commoditized products and no clear moat; margins can be squeezed by input prices.

AI Analysis

When I look at M K Proteins, I don't see the kind of business I want to own. Edible oil is a commodity product; there is little pricing power and no lasting moat. The numbers confirm that. The latest quarter shows ₹90 Cr of sales but only ₹1 Cr of net profit—a margin of about 1%. So while reported sales growth is 126.85%, profit growth is just 3.62%. Top-line growth without bottom-line growth is not economic value creation; it is often just inflated revenue with no benefit to owners. The balance sheet is the most positive part: debt/equity is 0.03 and the Piotroski F-Score is 7/9, so the company is not financially stressed. Promoter holding of 74.82% does align interests, though it also leaves little free float. The valuation is not attractive. At ₹5.33 I am paying a P/E of 22.46 and 3.03 times book value of ₹1.76. A 13% ROE and 12.87% ROCE are okay, but they do not justify a rich price for a commodity business with no dividend. The advertised PEG of 0.34 is misleading because it seems to rely on sales growth; the actual profit growth of 3.62% gives a very different picture. In Benjamin Graham's terms, I need a margin of safety. I don't find it here. I would wait for sustained margin expansion and consistent earnings before considering this as an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer